IP Verse

Method To Determine Responsiveness Of Cancer To Epidermal Growth Factor Receptor Targeting Treatments

Patent No. EP2439285 (titled "Method To Determine Responsiveness Of Cancer To Epidermal Growth Factor Receptor Targeting Treatments") was filed by Dana Farber Cancer Institute on Mar 31, 2005. The application was issued on May 8, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BOULT WADE TENNANTFeb 10, 2020BOULT WADE TENNANT
JAMES POOLEFeb 10, 2020CARPMAELS & RANSFORD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2439285

DANA FARBER CANCER INSTITUTE
Application Number
EP11178202A
Filing Date
Mar 31, 2005
Status
Granted And Under Opposition
Apr 5, 2019
Publication Date
May 8, 2019
External Links
Slate, Register , Google Patents